Monitor the EGM outcome on November 30, 2026, for any shareholder dissent or last-minute regulatory hurdles. The deal timeline remains intact with closing expected in early 2027.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 16 $33.44entry
- T+1 · 29d ago +0.72%α +0.29% · $33.68
- T+5 · 25d ago +4.81%α +4.72% · $35.05
- T+20 · 4d ago +8.88%α +10.04% · $36.41
- T+21 · todayOpen
- T+60 · in 8w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
AkzoNobel announced an Extraordinary General Meeting (EGM) on November 30, 2026, to approve the formal name change of the combined company to Axanzo N.V. (ticker AXZ) and appoint three non-executive directors. This is a procedural step in the all-share merger of equals with Axalta, confirming the deal is on track for closing in early 2027.
Key Financial Metrics
Key Facts
- AkzoNobel will hold an EGM on November 30, 2026, to vote on proposals related to the all-share merger of equals with Axalta.
- First proposal: amend articles of association to reflect the combined company's new name, Axanzo N.V., with ticker symbol AXZ.
- Other proposals: appoint Denise Johnson, Stephan Tanda, and Robert Schuchna as non-executive directors of the combined company.
- Closing expected in early 2027, subject to regulatory approvals and customary conditions.
- The merger was announced in November 2025; a definitive proxy statement was mailed on June 24, 2026.
Financial Impact
No financial figures disclosed; this is a procedural filing for shareholder approval of name change and director appointments.
Risk Factors
- Regulatory approvals may be delayed or subject to unexpected conditions.
- Shareholder vote at the EGM could face opposition, though no opposition has been disclosed.
- Integration risks post-closing could affect synergy realization.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0000950103-26-015694 |
| Document: 0000950103-26-015694-index-headers.html | 0000950103-26-015694 |
| Document: 0000950103-26-015694-index.html | 0000950103-26-015694 |
| Document: 0000950103-26-015694.txt | 0000950103-26-015694 |
Track record
44 reports on AXTA
5 of 10 bullish or bearish reports moved the stock their way by T+1. Best: +16.39% at T+60 after the Jun 3, 2026 report. 6 of 10 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry price pending
- Nov 12, 20264d ago SC 13G Neutral 3/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
- Nov 12, 20264d ago 425 Neutral 4/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
- Nov 12, 20264d ago 425 Neutral 4/10 Entry $36.41 to $36.56 Now $36.56 +0.41% ▲ +0.41% +0.78% vs SPY
- Nov 11, 20265d ago Press Release Neutral 4/10 Entry $37.07 to $36.41 Now $36.56 −1.38% ▼ −1.78% −1.43% vs SPY
- Nov 6, 202610d ago 425 Neutral 5/10 Entry $37.53 to $37.38 Now $36.56 −2.58% ▼ −0.40% −0.03% vs SPY
- Nov 6, 202610d ago 425 Bullish 6/10 Entry $36.45 to $37.53 Now $36.56 +0.30% ▲ +2.96% +0.60% vs SPY
- Nov 6, 202610d ago Press Release Bullish 5/10 Entry $36.45 to $37.53 Now $36.56 +0.30% ▲ +2.96% +0.60% vs SPY
- Oct 29, 202618d ago 425 Bearish 4/10 Entry $34.07 to $35.84 Now $36.56 −7.31% ▼ −5.20% −5.67% vs SPY
- Oct 29, 202618d ago 425 Neutral 4/10 Entry $34.07 to $35.84 Now $36.56 +7.31% ▲ +5.20% +5.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers